Adjuvant chemotherapy for treatment of unresectable and metastatic angiomatoid malignant fibrous histiocytoma

Cancer. 1994 Aug 1;74(3):962-4. doi: 10.1002/1097-0142(19940801)74:3<962::aid-cncr2820740327>3.0.co;2-a.

Abstract

Angiomatoid malignant fibrous histiocytoma (AMFH) is a low grade soft tissue sarcoma usually treated with surgery alone. Only one adult patient has been treated with systemic chemotherapy. The authors report a case of unresectable, metastatic AMFH treated initially with vincristine, doxorubicin, dactinomycin, and cyclophosphamide. A complete response at the metastatic site and a marked reduction in the size of the primary tumor allowed complete surgical excision 7 months after treatment was initiated. The patient remains disease free 19 months after being diagnosed. It was concluded that systemic chemotherapy may be effective in patients with AMFH.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Chemotherapy, Adjuvant
  • Child
  • Cyclophosphamide / administration & dosage
  • Dactinomycin / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Histiocytoma, Benign Fibrous / drug therapy*
  • Histiocytoma, Benign Fibrous / surgery
  • Humans
  • Neoplasm Metastasis
  • Soft Tissue Neoplasms / drug therapy*
  • Soft Tissue Neoplasms / surgery
  • Vincristine / administration & dosage

Substances

  • Dactinomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide